[1]
“STABILITY INDICATING HPTLC METHOD FOR SOFOSBUVIR AND VELPATASVIR IN COMBINATION”, Int. J. Pharm. Sci. Drug Res., vol. 12, no. 2, pp. 129–135, Mar. 2020, doi: 10.25004/IJPSDR.2020.120206.